http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-PI0408372-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a98cb1b197f761c87cd3caf32bc247e2 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-513 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-553 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-53 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 |
| filingDate | 2004-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_351ac32810036eca4cc0a3b781714915 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f11d541b7d9537064e6153adf064d90e |
| publicationDate | 2006-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | BR-PI0408372-A |
| titleOfInvention | antitumor effect enhancer and antitumor agent |
| abstract | "ANTITUMOR EFFECT POTENTIALIZER AND ANTITUMOR AGENT". The present invention provides an antitumor effect enhancer for enhancing antitumor activity of an antitumor agent comprising tegafur in a therapeutically effective amount, gimeracil in an antitumor enhancing effective amount, and oteracil potassium in an effective inhibitory amount of an antitumor. side effect, the antitumor effect enhancer comprising at least one member selected from the group consisting of folinic acid and its pharmacologically acceptable salts in an amount effective for enhancing an antitumor effect; an antitumor agent comprising, as active ingredients, tegafur in a therapeutically effective amount, gimeracil in an antitumor-enhancing effective amount, oteracil potassium in an amount effective to inhibit a side effect, and at least one member selected from the group consisting of folinic acid and its pharmacologically acceptable salts in an amount effective for enhancing an antitumor effect; a process for enhancing an antitumor effect of an antitumor agent comprising the step of administering to a patient the antitumor effect enhancer mentioned above; and a process for treating cancer comprising the step of administering to a patient the antitumor agent mentioned above. |
| priorityDate | 2003-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 32.